OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

ROCHE I/  CH0012032113  /

SIX Swiss Exchange
6/5/2024  5:31:05 PM Chg. +3.20 Volume Bid9:51:14 PM Ask9:51:14 PM Market Capitalization Dividend Y. P/E Ratio
262.80CHF +1.23% 28,936
Turnover: 7.61 mill.		 261.00Bid Size: 5 -Ask Size: 18 219.1 bill.CHF 3.61% 18.25
GlobeNewswire 6/5 Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
GlobeNewswire 6/5 Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity f...
TeleTrader 5/27 Roche shuffles its executive committee
TeleTrader 5/16 Roche notes progress in obesity drug trial
GlobeNewswire 5/14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 5/7 Enable Injections Expands Strategic Partnership with Roche
TeleTrader 4/24 Roche's logs 14.4 billion Swiss francs in Q1 sales
GlobeNewswire 4/3 UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Inju...
GlobeNewswire 4/2 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 4/1 AssetMark Honors Financial Advisors with Community Inspiration Award
GlobeNewswire 3/22 HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire 3/14 Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides C...
GlobeNewswire 2/26 Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...
GlobeNewswire 2/21 REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Rep...
GlobeNewswire 2/13 Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Busine...
GlobeNewswire 2/8 Accumulus Synergy Launches Highly Anticipated Cloud-Based Platform
TeleTrader 2/1 Roche's 2023 sales increase 1% to 58.7B Swiss francs
GlobeNewswire 1/30 COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha ...
GlobeNewswire 1/29 Carmot Therapeutics Announces Completion of Acquisition by Roche
GlobeNewswire 1/3 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 1/3 Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Tria...
GlobeNewswire 12/29/2023 LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
GlobeNewswire 12/14/2023 Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibo...
GlobeNewswire 12/13/2023 U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Scler...